{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:50:04Z","timestamp":1794019804762,"version":"4.8.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003995","name":"Anhui Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["2308085Y11"],"award-info":[{"award-number":["2308085Y11"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015801","name":"Anhui Provincial Quality Engineering Project","doi-asserted-by":"publisher","award":["2023zygzts154"],"award-info":[{"award-number":["2023zygzts154"]}],"id":[{"id":"10.13039\/100015801","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006247","name":"Anhui University of Science and Technology","doi-asserted-by":"publisher","award":["YZ2023H1A004"],"award-info":[{"award-number":["YZ2023H1A004"]}],"id":[{"id":"10.13039\/501100006247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejmech.2025.118209","type":"journal-article","created":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T20:09:30Z","timestamp":1759262970000},"page":"118209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Discovery of Y502-2304, a potent c-Myc G-quadruplex stabilizer for the treatment of multiple myeloma"],"prefix":"10.1016","volume":"301","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-0490","authenticated-orcid":false,"given":"Jian","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingting","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiacheng","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2025.118209_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"Kumar","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejmech.2025.118209_bib2","first-page":"44","article-title":"Senescence-like phenotype in monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) plasma cells","volume":"37","author":"Borges","year":"2022","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.ejmech.2025.118209_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1182\/blood.V126.23.2965.2965","article-title":"Urinary protein levels in monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM) predict severe disease related complications at myeloma progression","volume":"126","author":"Belotti","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2025.118209_bib4","first-page":"578","article-title":"Management of monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM)","volume":"25","author":"Kyle","year":"2011","journal-title":"Oncology-Ny"},{"key":"10.1016\/j.ejmech.2025.118209_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1517\/14728222.7.5.623","article-title":"The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth","volume":"7","author":"Pelengaris","year":"2003","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.ejmech.2025.118209_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2025.118209_bib7","article-title":"c-MYC-Induced genomic instability","volume":"4","author":"Kuzyk","year":"2014","journal-title":"Csh. Perspect Med."},{"key":"10.1016\/j.ejmech.2025.118209_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103756","article-title":"Therapeutic targeting of \"undruggable\" MYC","volume":"75","author":"Llombart","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ejmech.2025.118209_bib9","doi-asserted-by":"crossref","first-page":"6557","DOI":"10.1007\/s00018-021-03921-8","article-title":"G-quadruplex DNA: a novel target for drug design","volume":"78","author":"Teng","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.ejmech.2025.118209_bib10","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3390\/molecules27010140","article-title":"Folding and unfolding of exogenous G-Rich oligonucleotides in live cells by fluorescence lifetime imaging microscopy of o-BMVC fluorescent probe","volume":"27","author":"Tseng","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2025.118209_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111550","article-title":"G-quadruplex stabilization via small-molecules as a potential anti-cancer strategy","volume":"139","author":"Awadasseid","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2025.118209_bib12","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1177\/1947601910377493","article-title":"Targeting MYC expression through G-Quadruplexes","volume":"1","author":"Brooks","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ejmech.2025.118209_bib13","doi-asserted-by":"crossref","first-page":"41018","DOI":"10.1074\/jbc.M111.274720","article-title":"Demonstration that drug-targeted down-regulation of MYC in non-hodgkins lymphoma is directly mediated through the promoter G-quadruplex","volume":"286","author":"Brown","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2025.118209_bib14","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41375-018-0036-x","article-title":"Targeting MYC in multiple myeloma","volume":"32","author":"Jovanovic","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.ejmech.2025.118209_bib15","doi-asserted-by":"crossref","first-page":"8702","DOI":"10.1021\/ja040022b","article-title":"The dynamic character of the G-quadruplex element in the c-MYC promoter and modification by TMPyP4","volume":"126","author":"Seenisamy","year":"2004","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118209_bib16","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/febs.12734","article-title":"N-methylmesoporphyrin IX fluorescence as a reporter of strand orientation in guanine quadruplexes","volume":"281","author":"Sabharwal","year":"2014","journal-title":"FEBS J."},{"key":"10.1016\/j.ejmech.2025.118209_bib17","first-page":"3247","article-title":"The different biological effects of telomestatin and TMPyP4 can be attributed to their selectivity for interaction with intramolecular or intermolecular G-quadruplex structures","volume":"63","author":"Kim","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118209_bib18","doi-asserted-by":"crossref","first-page":"7653","DOI":"10.1158\/0008-5472.CAN-09-1304","article-title":"Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis","volume":"69","author":"Drygin","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2025.118209_bib19","article-title":"CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1\/2 deficient tumours","volume":"8","author":"Xu","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118209_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70034","article-title":"Discovery of voreloxin as a dual-selective stabilizer for c-Myc\/Bcl-2 G-Quadruplexes in leukemia","volume":"104","author":"Yin","year":"2024","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.118209_bib21","doi-asserted-by":"crossref","first-page":"16205","DOI":"10.1021\/acs.jmedchem.1c01508","article-title":"Berberine molecular recognition of the parallel MYC G-Quadruplex in solution","volume":"64","author":"Dickerhoff","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118209_bib22","doi-asserted-by":"crossref","first-page":"769","DOI":"10.3390\/ph14080769","article-title":"G-Quadruplexes and their ligands: biophysical methods to unravel G-Quadruplex\/Ligand interactions","volume":"14","author":"Santos","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.ejmech.2025.118209_bib23","doi-asserted-by":"crossref","first-page":"14788","DOI":"10.1021\/acsomega.8b01574","article-title":"Binding of telomestatin, TMPyP4, BSU6037, and BRACO19 to a telomeric G-Quadruplex-Duplex hybrid probed by all-atom molecular dynamics simulations with explicit solvent","volume":"3","author":"Sullivan","year":"2018","journal-title":"ACS Omega"},{"key":"10.1016\/j.ejmech.2025.118209_bib24","doi-asserted-by":"crossref","DOI":"10.4061\/2010\/525862","article-title":"\"one ring to bind them all\"-part I: the efficiency of the macrocyclic scaffold for g-quadruplex DNA recognition","volume":"2010","author":"Monchaud","year":"2010","journal-title":"J. Nucleic Acids"},{"key":"10.1016\/j.ejmech.2025.118209_bib25","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.biochi.2015.06.002","article-title":"Assessment of selectivity of G-quadruplex ligands via an optimised FRET melting assay","volume":"115","author":"De Rache","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.ejmech.2025.118209_bib26","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3390\/cancers13133156","article-title":"Quadruplex ligands in cancer therapy","volume":"13","author":"Sanchez-Martin","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.ejmech.2025.118209_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/cbdd.70146","article-title":"Thienopyrimidine: unveiling the versatile potential of a promising heterocyclic scaffold in drug discovery","volume":"105","author":"Nadar","year":"2025","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.ejmech.2025.118209_bib28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejmech.2018.01.091","article-title":"Targeting G-quadruplex DNA structures in the telomere and oncogene promoter regions by benzimidazole-carbazole ligands","volume":"148","author":"Kaulage","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118209_bib29","doi-asserted-by":"crossref","first-page":"3567","DOI":"10.1021\/bi1000849","article-title":"Specific high-affinity binding of thiazole Orange to triplex and G-Quadruplex DNA","volume":"49","author":"Lubitz","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2025.118209_bib30","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1021\/acschembio.2c00224","article-title":"R-BIND 2.0: an updated database of bioactive RNA-targeting small molecules and associated RNA secondary structures","volume":"17","author":"Donlic","year":"2022","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.ejmech.2025.118209_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113555","article-title":"Quinoline anticancer agents active on DNA and DNA-interacting proteins: from classical to emerging therapeutic targets","volume":"220","author":"Lauria","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118209_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115103","article-title":"The effect of side chain variations on quinazoline-pyrimidine G-quadruplex DNA ligands","volume":"248","author":"Bhuma","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118209_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.134673","article-title":"Design, synthesis, and biological evaluation of novel benzimidazolyl isoxazole derivatives as potential c-Myc G4 stabilizers to suppress c-Myc transcription and myeloma growth","volume":"1275","author":"Geng","year":"2023","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.ejmech.2025.118209_bib34","doi-asserted-by":"crossref","DOI":"10.1002\/minf.202200011","article-title":"Identification of trovafloxacin, ozanimod, and ozenoxacin as potent c-Myc G-quadruplex stabilizers to suppress c-Myc transcription and myeloma growth","volume":"41","author":"Zhang","year":"2022","journal-title":"Mol. Inform."},{"key":"10.1016\/j.ejmech.2025.118209_bib35","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1021\/jm020155c","article-title":"Do structurally similar molecules have similar biological activity?","volume":"45","author":"Martin","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118209_bib36","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1021\/jm060167o","article-title":"Do structurally similar ligands bind in a similar fashion?","volume":"49","author":"Bostrom","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2025.118209_bib37","doi-asserted-by":"crossref","first-page":"20446","DOI":"10.1021\/ja3088746","article-title":"Optimized end-stacking provides specificity of N-Methyl mesoporphyrin IX for human telomeric G-Quadruplex DNA","volume":"134","author":"Nicoludis","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118209_bib38","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1142\/S1088424619300179","article-title":"N-methyl mesoporphyrin IX as a highly selective light-up probe for G-quadruplex DNA","volume":"23","author":"Yett","year":"2019","journal-title":"J. Porphyr. Phthalocyanines"},{"key":"10.1016\/j.ejmech.2025.118209_bib39","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1038\/s41467-021-22830-9","article-title":"Single-molecule imaging reveals replication fork coupled formation of G-quadruplex structures hinders local replication stress signaling","volume":"12","author":"Lee","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2025.118209_bib40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41419-023-05562-0","article-title":"Crosstalk between G-quadruplex and ROS","volume":"14","author":"Wu","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.ejmech.2025.118209_bib41","doi-asserted-by":"crossref","first-page":"17673","DOI":"10.1021\/ja205646q","article-title":"Solution structure of a 2:1 Quindoline-c-MYC G-Quadruplex: insights into G-Quadruplex-Interactive small molecule drug design","volume":"133","author":"Dai","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2025.118209_bib42","series-title":"AMBER 2018","author":"Case","year":"2018"},{"key":"10.1016\/j.ejmech.2025.118209_bib43","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1002\/jcc.20035","article-title":"Development and testing of a general amber force field","volume":"25","author":"Wang","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejmech.2025.118209_bib44","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nmeth.3658","article-title":"Parmbsc1: a refined force field for DNA simulations","volume":"13","author":"Ivani","year":"2016","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejmech.2025.118209_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/srep42717","article-title":"SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523425009742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T11:20:11Z","timestamp":1773141611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523425009742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":45,"alternative-id":["S0223523425009742"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118209","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of Y502-2304, a potent c-Myc G-quadruplex stabilizer for the treatment of multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2025.118209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"118209"}}